Atlas Trials

The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)

Clinical trial NCT05971732 · UNKNOWN

Trial details

NCT number
NCT05971732
Sponsor
China-Japan Friendship Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Heart Failure With Reduced Ejection FractionIron DeficiencyAcute Heart Failure
Start date
2023-08-01
Primary completion
2024-08-01
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.